Oregon; General Obligation, State GO May 00

  • ID: 1754454
  • May 2000
  • Region: Oregon
  • Standard & Poors
1 of 3

The rating on Oregon's GO debt reflects: The continued diversification of the state's economic base, A strong overall revenue performance that has largely offset increased costs of funding education, A manageable debt burden despite additional capital needs associated with growth, and Improving fund balances resulting from the receipt of greater-than-expected personal income taxes. Somewhat offsetting these strengths are continued increased funding pressures as a result of growth and tax limitation measures. Oregon, with a population of about 3.3 million, has benefited in recent years from a strong revenue performance resulting from its growing economy and expanding population and labor force. The state has diversified away from a heavy reliance on timber and agriculture to a broader mix of high-technology, service,...

Companies mentioned in this report are:
- Oregon

Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.